Affinity DataKi: 0.0300nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0300nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0400nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0800nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: <0.100nM ΔG°: <-57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.100nM ΔG°: -57.1kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.25nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
Affinity DataKi: 0.260nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.300nM ΔG°: -54.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.300nMpH: 7.4Assay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.300nM ΔG°: -54.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.300nM ΔG°: -54.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.300nM ΔG°: -54.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataKi: 0.300nM ΔG°: -54.4kJ/molepH: 7.4 T: 2°CAssay Description:The CRTH2 receptor binding assay is performed in a scintillation proximity assay (SPA) format with the radioligand [3H]-PGD2 (Perkin Elmer, NET616000...More data for this Ligand-Target Pair
